The global Target Enrichment Solutions for Next-Generation Sequencing market size is predicted to grow from US$ 1157 million in 2025 to US$ 2688 million in 2031; it is expected to grow at a CAGR of 15.1% from 2025 to 2031.

Target Enrichment Solutions for Next-Generation Sequencing (NGS) are technologies and methods designed to selectively isolate and amplify specific regions of a genome for sequencing, reducing the cost and complexity of analyzing entire genomes. These solutions include tools like hybridization-based capture probes, amplicon-based enrichment methods, and CRISPR-based approaches, allowing researchers to focus on genes, regions, or mutations of interest. They are widely used in applications such as disease research, clinical diagnostics, drug development, and population genomics, enabling high-depth sequencing, improved sensitivity, and efficient data generation for targeted genomic studies.

United States market for Target Enrichment Solutions for Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Target Enrichment Solutions for Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Target Enrichment Solutions for Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Target Enrichment Solutions for Next-Generation Sequencing players cover Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, Integrated DNA Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Target Enrichment Solutions for Next-Generation Sequencing Industry Forecast” looks at past sales and reviews total world Target Enrichment Solutions for Next-Generation Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Target Enrichment Solutions for Next-Generation Sequencing sales for 2025 through 2031. With Target Enrichment Solutions for Next-Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Target Enrichment Solutions for Next-Generation Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Target Enrichment Solutions for Next-Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Target Enrichment Solutions for Next-Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Target Enrichment Solutions for Next-Generation Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Target Enrichment Solutions for Next-Generation Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Target Enrichment Solutions for Next-Generation Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Target Enrichment Solutions for Next-Generation Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Multiplex PCR-based (Amplicon Sequencing)
    Hybrid Capture-based

Segmentation by Application:

    Hospitals and Clinics
    Biopharma Companies
    Academic and Research Organizations
    Others

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Thermo Fisher Scientific
    Illumina
    Agilent Technologies
    QIAGEN
    Integrated DNA Technologies
    Twist Bioscience
    Takara Bio
    GenScript
    Roche Sequencing Solutions
    Oxford Gene Technology
    Pillar Biosciences
    Celemics
    Daicel Arbor Biosciences
    Nonacus
    Tecan
    Cantata Bio
    Paragon Genomics
    New England Biolabs
    Shanghai Dynegene Technologies